Skip to main content
Journal cover image

Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion.

Publication ,  Journal Article
Hurst, JH; Brucker, A; Zhao, C; Driscoll, H; Hostetler, HP; Phillips, M; Rosenberg, B; Samsky, MD; Smith, I; Reller, ME; Strouse, JJ; Zhou, CK ...
Published in: Drug Saf
March 2023

INTRODUCTION: Detection of adverse reactions to drugs and biologic agents is an important component of regulatory approval and post-market safety evaluation. Real-world data, including insurance claims and electronic health records data, are increasingly used for the evaluation of potential safety outcomes; however, there are different types of data elements available within these data resources, impacting the development and performance of computable phenotypes for the identification of adverse events (AEs) associated with a given therapy. OBJECTIVE: To evaluate the utility of different types of data elements to the performance of computable phenotypes for AEs. METHODS: We used intravenous immunoglobulin (IVIG) as a model therapeutic agent and conducted a single-center, retrospective study of 3897 individuals who had at least one IVIG administration between 1 January 2014 and 31 December 2019. We identified the potential occurrence of four different AEs, including two proximal AEs (anaphylaxis and heart rate alterations) and two distal AEs (thrombosis and hemolysis). We considered three different computable phenotypes: (1) an International Classification of Disease (ICD)-based phenotype; (2) a phenotype-based on EHR-derived contextual information based on structured data elements, including laboratory values, medication administrations, or vital signs; and (3) a compound phenotype that required both an ICD code for the AE in combination with additional EHR-derived structured data elements. We evaluated the performance of each of these computable phenotypes compared with chart review-based identification of AEs, assessing the positive predictive value (PPV), specificity, and estimated sensitivity of each computable phenotype method. RESULTS: Compound computable phenotypes had a high positive predictive value for acute AEs such as anaphylaxis and bradycardia or tachycardia; however, few patients had both ICD codes and the relevant contextual data, which decreased the sensitivity of these computable phenotypes. In contrast, computable phenotypes for distal AEs (i.e., thrombotic events or hemolysis) frequently had ICD codes for these conditions in the absence of an AE due to a prior history of such events, suggesting that patient medical history of AEs negatively impacted the PPV of computable phenotypes based on ICD codes. CONCLUSIONS: These data provide evidence for the utility of different structured data elements in computable phenotypes for AEs. Such computable phenotypes can be used across different data sources for the detection of infusion-related adverse events.

Duke Scholars

Published In

Drug Saf

DOI

EISSN

1179-1942

Publication Date

March 2023

Volume

46

Issue

3

Start / End Page

309 / 318

Location

New Zealand

Related Subject Headings

  • Retrospective Studies
  • Phenotype
  • Pharmacology & Pharmacy
  • Immunoglobulins, Intravenous
  • Humans
  • Hemolysis
  • Electronic Health Records
  • Anaphylaxis
  • Algorithms
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hurst, J. H., Brucker, A., Zhao, C., Driscoll, H., Hostetler, H. P., Phillips, M., … Goldstein, B. A. (2023). Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion. Drug Saf, 46(3), 309–318. https://doi.org/10.1007/s40264-023-01276-6
Hurst, Jillian H., Amanda Brucker, Congwen Zhao, Hannah Driscoll, Haley P. Hostetler, Michael Phillips, Bari Rosenberg, et al. “Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion.Drug Saf 46, no. 3 (March 2023): 309–18. https://doi.org/10.1007/s40264-023-01276-6.
Hurst JH, Brucker A, Zhao C, Driscoll H, Hostetler HP, Phillips M, Rosenberg B, Samsky MD, Smith I, Reller ME, Strouse JJ, Zhou CK, Dores GM, Wong H-L, Goldstein BA. Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion. Drug Saf. 2023 Mar;46(3):309–318.
Journal cover image

Published In

Drug Saf

DOI

EISSN

1179-1942

Publication Date

March 2023

Volume

46

Issue

3

Start / End Page

309 / 318

Location

New Zealand

Related Subject Headings

  • Retrospective Studies
  • Phenotype
  • Pharmacology & Pharmacy
  • Immunoglobulins, Intravenous
  • Humans
  • Hemolysis
  • Electronic Health Records
  • Anaphylaxis
  • Algorithms
  • 3214 Pharmacology and pharmaceutical sciences